The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

BEIJING, Jan 27 (Reuters) - Profits at China's industrial firms fell for a third straight year in 2024, official data showed on Monday, underlining the urgency for policymakers to step up support ...

The FDA’s latest approval of the nasal spray Spravato (esketamine) CIII marks a major shift in how major depressive disorder is managed, allowing people who have tried at least two oral ...

I saw that too." Auschwitz-Birkenau was a killing machine, with industrial ovens. Visitors to Auschwitz today who spend time in the barracks are stunned by the horror. Meter-high piles of human ...

CHAPIN, S.C. — Residents of Chapin are voicing their concerns over a new development proposed for the area. “It's just gonna make the quality of life for everybody who lives around it worse ...